Researchers confirm the validity of xenographic models for studies of methylation

(IDIBELL-Bellvitge Biomedical Research Institute) Researchers at the Bellvitge Biomedical Research Institute (IDIBELL), published today in Molecular Cancer Research a study where they identify methylation patterns associated with different subtypes of breast cancer, and a subclassification of the group of " triple negatives " , a breast cancer type typically associated with poor prognosis. In addition, researchers identified changes in DNA methylation associated with the response to docetaxel, a common therapy. The research was led by Dr. Eva Gonz á lez-Su á rez, head of the IDIBELL Transformation and Metastasis research group.

https://www.eurekalert.org/pub_releases/2019-07/ibri-rct071819.php

Source: EurekAlert! - Cancer - July 18, 2019 Category: Cancer & Oncology Source Type: news